Menu

Blog

Legal insights and highlights in product liability, dangerous drugs, and mesothelioma and asbestos cases.


Hip Replacement X-Ray

Texas Trial for 8 NY Plaintiffs Injured by DePuy Pinnacle Postponed

The trial against DePuy involving 8 New York plaintiffs injured by DePuy Pinnacle hip implants has been postponed. The trial was set to occur today on September 5th, 2017 before U.S. District Judge Ed Kinkeade in the Northern District of Texas. Judge Kinkeade currently presides over 9,300 cases alleging DePuy’s Pinnacle hip implants are defective.… Read More

Posted in: All

Left to right: femoral stem (with neck), femoral cup, acetabular cup.

DePuy Pinnacle Trial for 8 Plaintiffs begins September 5th

On August 25th, 2017 Judge Ed Kinkeade of the District Court for the Northern District of Texas, Dallas Division, ordered the jury trial of eight plaintiffs to begin on September 5th, 2017. The cases selected for the latest bellwether trial are as follows: Alicea, et al., v. DePuy Orthopaedics, Inc. et al., No. 3:15-cv-03489-K Barzel,… Read More

Posted in: All

Talc Orange Top Quarter Size

Verdict: $417 Million in First California Talcum Powder Jury Trial

Breaking:  A California jury has returned a verdict of $417 million against Johnson and Johnson for a woman who was diagnosed with ovarian cancer after using talcum powder products including Johnson and Johnson baby powder. The Johnson & Johnson Company and Johnson and Johnson Consumer Incorporated were defendants in the California jury trial, which awarded… Read More

Posted in: All

Example of 3 E-Cig MOD Vaporizers

Surgeon’s Case Report: Rise in Burns from Vape Battery Explosions

A case report in the May edition of the medical journal Burns notes that failing lithium-ion batteries are responsible for the uptick in new cases of battery explosion burns.  Batteries stored in e-cig or vape mod devices can suffer from a run-away chemical reaction and explode. The case report is titled “Canary in the coal mine—Initial… Read More

Posted in: All

FDA image

FDA requests Endo Pharmaceuticals pull Opana ER from the market

  The Food and Drug Administration (FDA) has requested Endo Pharmaceuticals pull Opana ER from the market. Opana ER is an extended-release opioid, or narcotic. The drug is heavily abused by patients and can lead to addictions, which can then lead to overdoses and death. The Center for Disease Control and Prevention (CDC) currently estimates… Read More

Posted in: All